4//SEC Filing
Tsonis Anastasios 4
Accession 0001437749-12-003408
CIK 0000806888other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 9:11 PM ET
Size
13.8 KB
Accession
0001437749-12-003408
Insider Transaction Report
Form 4
Tsonis Anastasios
Controller
Transactions
- Award
Stock Option (Right to Buy)
2012-04-02+322,500→ 322,500 totalExercise: $0.11Exp: 2022-04-02→ Common Stock (322,500 underlying)
Footnotes (4)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]25% of the options shall vest and become exercisable on the date which is one year after the date of grant.
- [F3]An additional 1/48th of the options initially granted will vest and be exercisable on the first day of each calendar month beginning on the first calendar month after the calendar month in which the options described in preceding footnote (2) vest and continuing for 35 additional consecutive calendar months until all such options are vested and fully exercisable.
- [F4]The options granted are subject to approval of shareholders and the Toronto Stock Exchange. If such approvals are not obtained, the options will expire.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeother
Related Parties
1- filerCIK 0001538904
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 9:11 PM ET
- Size
- 13.8 KB